AbCellera Biologics Inc. (ABCL): Weighted Average Diluted Shares
298.71M
Year ended 2025-12-31
-1.7%
3-year compound annual growth
+2.6%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 298.71M | +1.5% | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | 294.33M | +1.8% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | 289.17M | -8.2% | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | 314.83M | -1.1% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | 318.29M | +21.0% | 2024-02-20, From 2021-01-01 |
| 2020-12-31 | 263.13M | +73.9% | 2023-02-21, From 2020-01-01 |
| 2019-12-31 | 151.33M | n/a | 2022-02-25, From 2019-01-01 |